Intensive Behavioral Health Approaches to Tobacco Treatment
May 21, 2024, 11:00am-5:00pm ET | 9.5 CME hours | $300 course fee

Health care professionals have received little training in current advanced techniques for intensive behavioral approaches to improved tobacco use treatment. This training will assist clinicians with acquiring improved skills in behavioral interventions for tobacco use treatment. Through experiential training methods, participants will be able to demonstrate how to use a variety of behavioral interventions, from motivational interviewing to cognitive behavior therapy to mindfulness practice. The training will also practice how understanding cultural differences can improve behavioral counseling outcomes.

Topics:

• Foundational Behavioral Interventions

• Myths and misconceptions about counseling

• Motivational interviewing for increasing cessation outcomes

• Cognitive behavioral therapy in tobacco treatment

• Mindfulness approaches to tobacco treatment

• Implementing skills training in cessation treatment

• Implementing social support strategies into cessation treatment

• Practical approaches and cases

​

Course Faculty:

• Adam O. Goldstein, MD, MPH, Professor, UNC Family Medicine

• Michael Baca-Atlas, MD, Assistant Professor, UNC Family Medicine

• Kim Schoenbill, MD, MPH, Assistant Professor, UNC Family Medicine

• Susan Trout, LCSW, MSPH, NCTTP, UNC Family Medicine

• Eiman Newcomer, MCSW, LCAS, NCTTP, UNC Family Medicine

• Sarah Sterling, LCSW, LCAS, NCTTP, Team Lead, UNC Weight Management Program

​

Prerequisites: This is an advanced course designed for behavioral health providers who already have experience providing tobacco use treatment. The course would also be ideal for those who wish to increase their knowledge about advanced behavioral health approaches for tobacco use treatment. It is not recommended for individuals who have no prior experience with behavioral health approaches treatment of tobacco use; those individuals would benefit from our full tobacco treatment specialist training program.

Tobacco Dependence Pharmacotherapy
May 9, 2024 | 12:00-5:00pm ET | 8.0 CME hours | $300 course fee

Medication strategies for tobacco use continue to evolve, with the use of pre-quit treatment, extended treatment, low-dose varenicline, high-dose nicotine, and combination treatment. Most medical providers are unaware of how or when to use these effective approaches.

This training is designed for physicians, physician assistants, nurse practitioners, pharmacists and tobacco treatment specialists who work with smoking cessation medications and would benefit from an understanding of the current research guiding smoking cessation pharmacotherapy. The course will provide an overview of the neurobiology that gives rise to nicotine dependence and how various medications impact that neurobiology. We will provide guidance on treatment that is relevant to most clinicians including:

​

• approaches to varenicline use that maximize efficacy and minimize side effects;

• use of combination medication treatment

• evidence for the use of pre-quit smoking cessation medications

• use of extended post-quit medications

• and the use of adaptive treatment

We explore specific cases, such as use of tobacco treatment medications in hospitalized patients, surgical patients, acute cardiac care, renal failure, cancer treatment, e-cigarette use, oral tobacco use, and adolescent treatment, as well as treatment of light-intermittent smokers and high-dependence smokers. The course is designed to provide practical guidance for clinicians and lead to real change in clinical practice.​

​

Course Faculty:

• Dr. James Davis, Director, Duke Smoking Cessation Program

• Kelly Young, PA-C, Duke Smoking Cessation Program

​

Prerequisites: This is an advanced course designed for physicians, physician assistants, nurse practitioners, and pharmacists who work with smoking cessation medications. The course would also be ideal for individuals who have already received training as a tobacco treatment specialist and wish to deepen their knowledge about pharmacotherapy for tobacco use treatment.